Lakewood-Amedex Highlights Nu-3 Against Antibiotic Resistance
SARASOTA, Fla., July 22, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced new preclinical resistance data supporting its lead antimicrobial candidate...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SARASOTA, Fla., July 22, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced new preclinical resistance data supporting its lead antimicrobial candidate...
SALT LAKE CITY, July 22, 2026 Co-Diagnostics, Inc. has announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd.,...
Acton, Massachusetts, USA | July 21, 2026 Bluejay Diagnostics has announced the successful completion of patient enrollment in its...
Innovative Diagnostics Target Critical Drug Resistance February 18, 2026 | Santa Maria, California U.S. Food and Drug Administration has...
HALIFAX, NOVA SCOTIA | December 30, 2025 — MedMira Inc. reported its first-quarter FY2026 results, highlighting a pivotal period...
